David J. Maloney

CSO
Veralox Therapeutics
Frederick, Maryland, United States

Presentation(s):

• OC 14.3 - A novel strategy to combat the procoagulant phenotype in immune thrombotic thrombocytopenia using 12-LOX inhibition

  Sunday, June 25, 2023
  11:15 – 11:30 ET